{"database": "lobbying", "table": "lobbying_activities", "rows": [[2286540, "d7770ffc-e2ff-418d-9434-8d570c4c7f56", "Q1", "JOHNSON & JOHNSON SERVICES, INC.", 20686, "JOHNSON & JOHNSON SERVICES INC", 2019, "first_quarter", "HCR", "- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions\n- S. 726 - Personal Care Products Safety Act, regarding all provisions\n- H.R. 269 - Pandemic and All-Hazards Preparedness & Advancing Innovation Act of 2019, regarding all provisions\n- Issues related to the reputation of over-the-counter drugs\n- Issues related to cosmetic regulatory reform\n- Issues related to cosmetic animal testing\n- Issues related to biosimilars\n- Issues related to maternal mortality\n- Issues related to contact lens safety\n- Issues related to the medical device tax repeal\n- Issues related to medical product communications\n- Issues related to medical product review\n- Issues related to talc safety\n- Issues related to drug pricing reform\n- Issues related to diversity in clinical trials\n- Issues related to health care pricing transparency\n- Issues related to peripheral artery disease", "HOUSE OF REPRESENTATIVES,SENATE,White House Office", null, 1440000, 0, 0, "2019-04-22T14:26:16.577000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2286540"], "units": {}, "query_ms": 0.38871506694704294, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}